383 related articles for article (PubMed ID: 9291432)
41. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations.
Dellas A; Moch H; Schultheiss E; Feichter G; Almendral AC; Gudat F; Torhorst J
Gynecol Oncol; 1997 Oct; 67(1):27-33. PubMed ID: 9345352
[TBL] [Abstract][Full Text] [Related]
42. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection.
Nair P; Nair KM; Jayaprakash PG; Pillai MR
Pathol Oncol Res; 1999; 5(2):95-103. PubMed ID: 10393359
[TBL] [Abstract][Full Text] [Related]
43. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
44. Assessment of EGFR and TGF-alpha expression in relationship to HPV status and Ki-67 distribution in cervical intraepithelial neoplasms.
Dellas A; Schultheiss E; Almendral AC; Torhorst J; Gudat F
Int J Cancer; 1996 Jun; 69(3):165-9. PubMed ID: 8682581
[TBL] [Abstract][Full Text] [Related]
45. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
46. [Immunohistochemical examinations of dyskeratosis and exocervical neoplasia in gynecological pathology].
Frolova II; Mestergazi GM; Radzinskiĭ VE; Sheliastina NN; Babichenko II
Arkh Patol; 2002; 64(6):23-6. PubMed ID: 12534223
[TBL] [Abstract][Full Text] [Related]
47. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation.
Saito H; Tsujitani S; Oka S; Ikeguchi M; Maeta M; Kaibara N
Ann Surg Oncol; 2002 Jun; 9(5):450-6. PubMed ID: 12052755
[TBL] [Abstract][Full Text] [Related]
48. Papillary squamous cell carcinoma of the uterine cervix: an immunophenotypic appraisal of 12 cases.
Mirhashemi R; Ganjei-Azar P; Nadji M; Lambrou N; Atamdede F; Averette HE
Gynecol Oncol; 2003 Sep; 90(3):657-61. PubMed ID: 13678741
[TBL] [Abstract][Full Text] [Related]
49. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.
Hoppe-Seyler F; Butz K
J Virol; 1993 Jun; 67(6):3111-7. PubMed ID: 8388491
[TBL] [Abstract][Full Text] [Related]
50. Histopathological study of the spreading neoplastic cells in cervical glands and surface epithelia in cervical intra-epithelial neoplasia and microinvasive squamous cell carcinoma: Ki-67 immunostaining is a useful marker for pathological diagnosis from the gland involvement site.
Kimura M; Matsumoto T; Morizane T; Sonoue H; Ogishima D; Kinoshita K
Pathol Int; 2006 Aug; 56(8):428-33. PubMed ID: 16872436
[TBL] [Abstract][Full Text] [Related]
51. Mdm2 and the p53 pathway in human pituitary adenomas.
Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH
Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M
Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280
[TBL] [Abstract][Full Text] [Related]
53. Differential diagnosis of atypical epithelium of biopsied gastric mucosa using immunostaining of Ki-67, p53, hMLH1 and MDM2 expression.
Ito E; Saito K; Takizawa T; Koike M
J Exp Clin Cancer Res; 2002 Dec; 21(4):527-37. PubMed ID: 12636099
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
[TBL] [Abstract][Full Text] [Related]
55. Papillomavirus, p53 alteration, and primary carcinoma of the vulva.
Pilotti S; D'Amato L; Della Torre G; Donghi R; Longoni A; Giarola M; Sampietro G; De Palo G; Pierotti MA; Rilke F
Diagn Mol Pathol; 1995 Dec; 4(4):239-48. PubMed ID: 8634779
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical detection of p53 protein in anogenital lesions and its relationship with HPV status.
Caruso ML; Valentini AM
Anticancer Res; 1998; 18(6A):4097-100. PubMed ID: 9891451
[TBL] [Abstract][Full Text] [Related]
57. Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
Helland A; Karlsen F; Due EU; Holm R; Kristensen G; Børresen-Dale Al
Br J Cancer; 1998 Jul; 78(1):69-72. PubMed ID: 9662253
[TBL] [Abstract][Full Text] [Related]
58. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
59. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions.
Maeda MY; Simões M; Wakamatsu A; Longatto Filho AL; Oyafuso M; de Mello ES; Otta MM; Alves VA
Pathologica; 2001 Jun; 93(3):189-95. PubMed ID: 11433611
[TBL] [Abstract][Full Text] [Related]
60. Changes of Ki-67 index in squamous cell carcinoma of the cervix during the early course of radiotherapy and prediction of prognosis.
Kamer SA; Yalman D; Ozer E; Sayhan S; Hanhan M; Ozsaran A; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):287-92. PubMed ID: 12807242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
